Antibiotic treatment for newborns with congenital syphilis
Treatments studied
Part of Genetic & congenital, Infections clinical trials.
This study tests a new way to give antibiotics to newborns who were exposed to syphilis during pregnancy. It may help clear the infection and prevent long-term problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- The baby is 30 days old or younger.
- The baby was born at 35 weeks of pregnancy or later.
- The baby weighs at least 750 grams.
- The baby is feeding by mouth without problems.
- The mother had syphilis during pregnancy and did not receive full treatment, or there is no record of treatment.
- The baby has not already received antibiotics that fight syphilis (like penicillin or certain other antibiotics).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving oral antibiotics at home is as safe and effective as the usual injections for newborns exposed to syphilis during pregnancy. It is for babies who appear healthy at birth.
This study compares two types of small IV catheters (long vs short) placed using ultrasound guidance in newborns with congenital syphilis who need 10 days of intravenous penicillin. The goal is to see which catheter type works better for delivering the medicine.
This study is testing a quick, bedside test for syphilis in mothers and their newborns at a hospital in Uganda. If you've had a positive syphilis test during pregnancy, this study might help ensure your baby gets the right care quickly.
This study tests whether taking an antibiotic (penicillin) during pregnancy can prevent syphilis infection in women who are at higher risk. If you are pregnant and have certain risk factors, this trial may help keep you and your baby safe from syphilis.
This study is testing a new, faster way to check for syphilis in pregnant people, new mothers, and their newborns, as well as in men and non-pregnant people at a Harris Health clinic. The goal is to make sure more people get the right treatment quickly.
This Phase 3 study tests whether cefixime can treat primary, secondary, or early latent syphilis. It may help by offering another effective antibiotic option, including for some people who also have HIV (if well controlled).
Hear when a new Syphilis, Congenital trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.